Modeling A Field Trial of the RTS,S/AS02A Malaria Vaccine

American Journal of Tropical Medicine and Hygiene

Volumn 75, Issue SUPPL. 2, 2006, Pages 104-110

  Maire, Nicolas ^a   Aponte, John J ^b   Ross, Amanda ^a   Thompson, Ricardo ^c   Alonso, Pedro ^b   Utzinger, Jürg ^a   Tanner, Marcel ^a   Smith, Thomas ^a  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUTO NACIONAL DE SAÚDE   (Mozambique)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE;

ARTICLE; BIOLOGICAL MODEL; COMPUTER SIMULATION; HUMAN; IMMUNOLOGY; INCIDENCE; INFANT; MALARIA FALCIPARUM; MOZAMBIQUE; PHASE 2 CLINICAL TRIAL; PRESCHOOL CHILD; STATISTICAL MODEL; STATISTICS;

CHILD, PRESCHOOL; CLINICAL TRIALS, PHASE II; COMPUTER SIMULATION; HUMANS; INCIDENCE; INFANT; MALARIA VACCINES; MALARIA, FALCIPARUM; MODELS, BIOLOGICAL; MODELS, STATISTICAL; MOZAMBIQUE; STOCHASTIC PROCESSES;

EID: 33748560490     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2006.75.104     Document Type: Article

References (23)

1. Alonso PL, Sacarlal J, Aponte J, Leach A, Macete E, Milman J, Mandomando I, Spiessens B, Guinovart C, Espasa M, Bassat Q, Aide P, Ofori-Anyinam O, Navia MM, Corachan S, Ceuppens M, Dubois MC, Demoitie MA, Dubovsky F, Menendez C, Tornieporth N, Ballou WR, Thompson R, Cohen J, 2004. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 364: 1411-1420.
2. Bojang K, Milligan PJM, Pinder M, Vigneron L, Alloueche A, Kester KE, Ballou WR, Conway D, Reece WHH, Gothard P, Yamuah L, Delchambre M, Voss G, Greenwood BM, Hill A, McAdam KP, Tornieporth N, Cohen JD, Doherty T, 2001. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet 358: 1927-1934.
3. Halloran ME, Haber M, Longini IM Jr, 1992. Interpretation and estimation of vaccine efficacy under heterogeneity. Am J Epidemiol 136: 328-343.
4. Halloran ME, Longini IM Jr, Struchiner CJ, 1996. Estimabilityand interpretation of vaccine efficacy using frailty mixing models. Am J Epidemiol 144: 83-97.
5. Alonso PL, Molyneux ME, Smith T, 1995. Design and methodology of field-based intervention trials of malaria vaccines. Parasitol Today 11: 197-200.
6. Smith T, Schellenberg JA, Hayes R, 1994. Attributable fraction estimates and case definitions for malaria in endemic areas. Stat Med 13: 2345-2358.
7. Schellenberg JR, Smith T, Alonso PL, Hayes R, 1994. What is clinical malaria? Finding case definitions for field research in highly endemic areas. Parasitol Today 10: 439-442.
8. Smith T, Maire N, Dietz K, Killeen GF, Vounatsou P, Molineaux L, Tanner M, 2006. Relationships between the entomologic inoculation rate and the force of infection for Plasmodium falciparum malaria. Am J Trop Med Hyg 75 (Suppl 2): 11-18.
9. Maire N, Smith T, Ross A, Owusu-Agyei S, Dietz K, Molineaux L, 2006. A model for natural immunity to asexual blood stages of Plasmodium falciparum in endemic areas. Am J Trop Med Hyg 75 (Suppl 2): 19-31.
10. Ross A, Maire N, Molineaux L, Smith T, 2006. An epidemiologic model of severe morbidity and mortality caused by Plasmodium falciparum. Am J Trop Med Hyg 75 (Suppl 2): 63-73.
11. Smith T, Ross A, Maire N, Rogier C, Trape JF, Molineaux L, 2006. An epidemiologic model of the incidence of acute illness in Plasmodium falciparum malaria. Am J Trop Med Hyg 75 (Suppl 2): 56-62.
12. Alonso PL, Saute F, Aponte J, Gomez-Olivé FX, Nhacalo A, Thompson R, Macete E, Abacassamo F, Ventura PJ, Bosch X, Mendendez C, Dgedge M, 2002. Manhiça DSS, Mozambique. INDEPTH Network, ed. Population, Health and Survival at INDEPTH Sites. Ottawa, Ontario, Canada: International Development Research Centre.
13. Aranda C, Aponte JJ, Saute F, Casimiro S, Pinto J, Sousa C, do Rosario V, Petrarca V, Dgedge M, Alonso P, 2005. Entomological characteristics of malaria transmission in Manhiça, arural area in southern Mozambique. J Med Entomol 42: 180-186.
14. Smith T, Killeen G, Maire N, Ross A, Molineaux L, Tediosi F, Hutton G, Utzinger J, Dietz K, Tanner M, 2006. Mathematical modeling of the impact of malaria vaccines on the clinical epidemiology and natural history of Plasmodium falciparum malaria: overview. Am J Trop Med Hyg 75 (Suppl 2): 1-10.
15. Saute F, Aponte J, Almeda J, Ascasco C, Vaz N, Dgedge M, Alonso P, 2003. Malaria in southern Mozambique: incidence of clinical malaria in children living in a rural community in Manhiça district. Trans R Soc Trop Med Hyg 97: 665-660.
16. Goodman CA, Coleman PG, Mills A, 2000. Economic Analysis of Malaria Control in sub-Saharan Africa. Geneva: Global Forum for Health Research.
17. McCombie SC, 1996. Treatment seeking for malaria: a review of recent research. Soc Sci Med 43: 933-945.
18. Hudgens MG, Gilbert PB, Self SG, 2004. Endpoints in vaccine trials. Stat Methods Med Res 13: 89-114.
19. Rogier C, Trape JF, 1995. Study of premunition development in holo- and meso-endemic malaria areas in Dielmo and Ndiop (Senegal): preliminary results, 1990-1994. Med Trop (Mars) 55: 71-76.
20. Trape JF, Rogier C, 1996. Combating malaria morbidity and mortality by reducing transmission. Parasitol Today 12: 236-240.
21. McKenzie FE, Samba EM, 2004. The role of mathematical modeling in evidence-based malaria control. Am J Trop Med Hyg 71 (Suppl 2): 94-96.
22. Glynn JR, Bradley DJ, 1995. Inoculum size, incubation period and severity of malaria. Analysis of data from malaria therapy records. Parasitology 110: 7-19.
23. Kester KE, McKinney DA, Tornieporth N, Ockenhouse CF, Heppner DG, Hall T, Krzych U, Delchambre M, Voss G, Dowler MG, Palensky J, Wittes J, Cohen J, Ballou WR; RTS,S Malaria Vaccine Evaluation Group, 2001. Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria. J Infect Dis 183: 640-647.